The AKITA® JET nebulizer is a new inhalation device with breath controlled inhalation. It regulates inspiration flow as well as inhalation volume, taking into account therapeutic requirements and the patient's individual condition. Doing so, it…
ID
Bron
Verkorte titel
Aandoening
Cystic Fibrosis
Inhalation therapy
AKITA® JET nebuliser
Ondersteuning
Laarbeeklaan 101, 1090 Jette
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
1. Quality of Life;<br>
2. FEV1;<br>
3. LCI;<br>
4. CT Bhalla score.
Achtergrond van het onderzoek
The AKITA® JET nebulizer is a new inhalation device with breath controlled inhalation. It regulates inspiration flow as well as inhalation volume, taking into account therapeutic requirements and the patient's individual condition. Doing so, it optimizes inhalation patterns, and ensures a higher drug deposition in the lungs.
In this project, we want to examine the influence of the use of the AKITA® JET inhalation device on clinical scores, quality of life, pulmonary function and imaging in patients with cystic fibrosis.
Doel van het onderzoek
The AKITA® JET nebulizer is a new inhalation device with breath controlled inhalation. It regulates inspiration flow as well as inhalation volume, taking into account therapeutic requirements and the patient's individual condition. Doing so, it optimizes inhalation patterns, and ensures a higher drug deposition in the lungs.
In this project, we want to examine the influence of the use of the AKITA® JET inhalation device on clinical scores, quality of life, pulmonary function and imaging in patients with cystic fibrosis.
Onderzoeksopzet
Visit 1: Before starting with AKITA;
Visit 2: After 6 weeks;
Visit 3: After 3 months.
Onderzoeksproduct en/of interventie
Patients will use the AKITA® JET inhalation device to inhale their medication for 3 months.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Patients with cystic fibrosis (6-65 years);
2. Treated with inhalation medication;
3. Never used AKITA® JET before.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Patients younger than 6 years;
2. Acute pulmonary exacerbation at day of inclusion.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL3334 |
| NTR-old | NTR3627 |
| Ander register | MEC UZ Brussel : 2012/185 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |